Dermatitis News

There was a significant difference in thickness of the granular layer in patients with palmar psoriasis vs. those with hand eczema, according to study results recently published in the Journal of the American Academy of Dermatology.

Atopic dermatitis was significantly associated with 11 of 22 examined autoimmune diseases and with having multiple autoimmune diseases, especially in smokers, according to study results published in Journal of the American Academy of Dermatology.

Reported race and ethnic diversity of research cohorts is lacking in dermatology clinical trials, particularly within international trials, according to study results published in JAMA Dermatology.

Mark S. Nestor, MD, PhD, symposium chair, spoke with Healio.com/Aesthetics about the highlights of the upcoming South Beach Symposium in Miami, including the exhibit hall, practice management panels and live patient demonstrations.

Along with live workshops and educational presentations from top industry leaders, the 15th annual South Beach Symposium, scheduled for Feb. 9 to 12 in Miami, will feature a panel roundtable of CEO’s from leading aesthetics and dermatology companies as well as showcase new products in the pipeline, according to a press release.

Although certain laser treatments may be beneficial in postinflammatory hyperpigmentation, previous clinical studies have often lacked a quality level of evidence, according to a systematic review published in JAMA Dermatology.

The establishment of defined treatment targets for patients with psoriasis was among the most-read articles in December on Healio.com/Dermatology.

Research finding that anti-programmed cell death-1 therapy for melanoma was associated with eczema and vitiligo was among the most-read articles in 2016 regarding melanoma on Healio.com/Dermatology.

Research funding that psoriasis had a strong association with type 2 diabetes and obesity in a nationwide study of Danish twins was among the 10 most-read articles of 2016 on Healio.com/Dermatology.

Novartis announced in a press release it has entered into an agreement to acquire Ziarco Group Limited, a privately held company focused on developing novel treatments in dermatology.